| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |